Cranberry and its phytochemicals: A review of in vitro anticancer studies

Journal of Nutrition

Volumn 137, Issue 1, 2007, Pages

  Neto, Catherine C ^a  

^a UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CRANBERRY EXTRACT; CYANIDIN; CYTOCHROME C; FLAVONOID; MATRIX METALLOPROTEINASE; MYRICETIN; PEONIDIN; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; PROSTAGLANDIN SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; QUERCETIN; UNCLASSIFIED DRUG; URSOLIC ACID;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BREAST TUMOR; CANCER CELL; CANCER INVASION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CRANBERRY; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; METASTASIS; PHYTOCHEMISTRY; PROSTATE TUMOR; PROTEIN EXPRESSION;

VACCINIUM MACROCARPON;

EID: 33846021239     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.1.186s     Document Type: Conference Paper

References (79)

1. Howell A, Vorsa N, Der Marderosian A, Foo L. Inhibition of adherence of P-fimbricated Escherischia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med. 1998;339:1085-6.
2. Foo LY, Lu Y, Howell AB, Vorsa N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod. 2000;63:1225-8.
3. Burger O, Ofek I, Tabak M, Weiss EI, Sharon N, Neeman I. A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol. 2000;29:295-301.
4. Zhang L, Ma J, Pan K, Go VL, Chen J, You WC. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter. 2005;10:139-45.
5. Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: Fruits. J. Agric. Food Chem. 2001;49:5315-21.
6. Yan X, Murphy BT, Hammond GB, Vinson JA, Neto CC. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2002;50:5844-9.
7. 2+-induced oxidation. J Sci Food Agric. 2001;81:1306-13.
8. Neto CC, Sweeney-Nixon MI, Lamoureaux TL, Solomon F, Kondo M, MacKinnon SL. Cranberry phenolics: Effects on oxidative processes, neuron cell death and tumor cell growth. In Shahidi F, Ho C-T, editors. Symposium Series No. 909: Phenolic Compounds in Foods and Natural Health Products Columbus, OH: ACS Books; 2005, pp. 271-282.
9. Youdim KA, McDonald J, Kalt W, Joseph JA. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem. 2002;13:282-8.
10. Bomser J, Madhavi DL, Singletary K, Smith MA. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med. 1996;62:212-6.
11. Guthrie N. Effect of cranberry juice and products on human breast cancer cell growth. San Diego: Experimental Biology; 2000.
12. Ferguson P, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr. 2004;134:1529-35.
13. Neto CC, Vaisberg AJ, Zhou B-N, Kingston DGI, Hammond GB. Cytotoxic triterpene acids from the peruvian medicinal plant Polylepis racemosa. Planta Med. 2000;66:483-4.
14. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren J, Bokesch H, Kenney S, Boyd M. New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst. 1990;82:1107-12.
15. Kandil FE, Smith MAL, Rogers RB, Pepin M-F, Song LL, Pezzuto JM, Seigler DS. Composition of a chemopreventive proantho-cyanidin-rich fraction from cranberry fruits responsible for the inhibition of TPA-induced ODC activity. J Agric Food Chem. 2002;50:1063-9.
16. Seeram, N. P., Adams, LS, Hardy ML, Heber D. Total cranberry extract vs. its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem. 2004;52:2512-7.
17. Murphy BT, MacKinnon SL, Yan X, Hammond GB, Vaisberg AJ, Neto CC. Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2003;51:3541-5.
18. Lee LT, Huang YT, Hwang JJ. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002;22:1615-27.
19. Choi J, Kim J, Lee J, Kang C, Kwon H, Yoo Y, Kim T, Lee Y, Lee S. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol. 2001;19:837-44.
20. Ramos S, Alia M, Bravo L, Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem. 2005;53:1271-80.
21. Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Cancer. 1999;34:88-99.
22. Ranelletti FO, Maggiano N, Serra FG. Quercetin inhibits p21-ras expression in human colon cancer cell lines and in primary colorectal tumors. Int J Cancer. 2000;85:438-45.
23. Morrow DMP, Fitzsimmons PEE, Chopra M, McGlynn H. Dietary supplementation with the antitumor promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutat Res. 2001;480:269-76.
24. Harris DM, Besselink E, Henning SM, Go VLW, Heber D. Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp Biol Med. 2005;230:558-68.
25. Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis. 2005;26:1450-6.
26. Fuleki T, Francis FJ. Quantitative methods for anthocyanins. Purification of cranberry anthocyanins. J Food Sci. 1968;33:266-9.
27. Wang SY, Stretch AW. Antioxidant capacity in cranberry is influenced by cultivar and storage temperature. J Agric Food Chem. 2001;49:969-74.
28. Vvedenskaya IO, Vorsa N. Flavonoid composition over fruit development and maturation in American cranberry, Vaccinium macrocarpon Ait. Plant Sci. 2004;167:1043-54.
29. Vorsa N, Howell AB, Foo LY, Lu Y. Structure and genetic variation of cranberry proanthocyanidins that inhibit adherence of uropathogenic P-fimbriated E. coli. In Shahidi F, editor. Food factors in health promotion and disease prevention. Columbus, OH: ACS Books; 2003, pp. 298-311. ACS Books.
30. Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK. Antiangiogenic property of edible berries. Free Radic Res. 2002;36:1023-31.
31. Bagchi D, Sen CK, Bagchi M, Atalay M. Anti-angiogenic, antioxidant and anticarcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc). 2004;69:75-80.
32. Atalay M, Gordillo G, Roy S, Rovin B, Bagchi D, Bagchi M, Sen CK. Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett. 2003;544:252-7.
33. Neto CC, Krueger CG, Lamoureaux TL, Kondo M, Vaisberg AJ, Hurta RAR, Curtis S, Matchett MD, Yeung H, et al. MALDI-TOF MS characterization of proanthocyanidins from cranberry fruit (Vaccinium macrocarpon) that inhibit tumor cell growth and matrix metalloproteinase expression in vitro. J Sci Food Agric. 2006;86:18-25.
34. Liberty AM, Hart P, Neto CC. Ursolic acid and proanthocyanidins from cranberry (Vaccinium macrocarpon) inhibit tumor colony formation and proliferation in HCT-116 and HT-29 colon tumor cells. Annual Meeting of the American Society of Pharmacognosy, Washington, DC; 2006.
35. Ye X, Krohn RL, Liu W, Joshi SS, Kuszynski CA, McGinn TR, Bagchi M, Preuss HG, Shohs SJ, Bagchi D. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem. 1999;196:99-108.
36. Agarwal C, Sharma Y, Zhao J, Agarwal R. A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases and inducing G1 arrest and differentiation. Clin Cancer Res. 2000;6:2921-30.
37. Kim H, Hall P, Smith M, Kirk M, Prasain JK, Barnes S, Grubbs C. Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J Nutr. 2004;134:3445S-52S.
38. Mantena SK, Baliga MS, Katiyar SK. (2006) Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis 2006;27:1682-91.
39. Zhao J,Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin twostage initiation-promotion protocol and identification of prycyanidin B5-3′ gallate as the most effective antioxidant constituent. Carcinogenesis. 1999;20:1737-45.
40. Singletary KW, Meline B. Effect of grape-seed proanthocyanidins on colon aberrant crypts and breast tumors in a rat dual-organ tumor model. Nutr Cancer. 2001;39:252-8.
41. DeFreitas VAP, Glories Y, Bourgeois G, Vitry C. Characterisation of oligomeric and polymeric procyanidins from grape seeds by liquid secondary ion mass spectrometry. Phytochemistry. 1998;49:1435-41.
42. Kolodziej H, Haberland C, Woerdenbag HJ, Konings AWT. Moderate cytotoxicity of proanthocyanidins to human tumour cell lines. Phytother Res. 1995;9:410-5.
43. Schmidt BM, Erdman JW, Lila MA. Differential effects of blueberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines. Cancer Lett. 2006;231:240-6.
44. Kondo M. Phytochemical studies of extracts from cranberry (Vaccinium macrocarpon) with anticancer, antifungal and cardioprotective properties. North Dartmouth, MA: University of Massachusetts Dartmouth; 2006, pp. 71-97.
45. Wang M, Li J, Shao Y, Huang T-C, Huang M-T, Chin C-K, Rosen RT, Ho C-T. Antioxidative and cytotoxic components of highbush blueberry (Vaccinium corymbosum L.). In Phytochemicals and phytopharmaceuticals. Champaign, IL: AOCS Press; 2000, pp. 271-7.
46. Kim KA, Lee J-S, Park H-J, Kim J-W, Kim C-J, Shim I-S, Kim N-J, Han S-M, Lim S. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci. 2004;74:2769-79.
47. 2 consumption, and tumor interstitial fluid pressure. Anticancer Res. 2001;21:2827-33.
48. Novotny L, Vachalkova A, Biggs D. Ursolic acid: an anti-tumorigenic and chemopreventive activity minireview. Neoplasma. 2001;48:241-6.
49. Es-saady D, Simon A, Ollier M, Maurizis JC, Chulia AJ, Delage C. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett. 1996;106:193-7.
50. 1 through ursolic acid and increased reduction of tetrazolium salts. Anticancer Res. 1996;16:481-486.
51. 2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J Cancer. 1997;73:725-8.
52. Kim D-K, Baek JH, Kang C-M, Yoo M-A, Sung J-W, Kim D-K, Chung H-Y, Kim N-D, Choi Y-H, et al. Apoptotic activity of ursolic acid may correlated with the inhibition of initiation of DNA replication. Int J Cancer. 2000;87:629-36.
53. Choi Y-H, Baek J-H, Yoo M-A, Chung H-Y, Kim N-D, Kim K-W. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. Int J Oncol. 2000;17:565-71.
54. Andersson D, Liu J-J, Nilsson A, Duan R-D. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res. 2003;23:3317-22.
55. Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Park BC, Kim KW. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res. 1996;56:2281-4.
56. Lambert JD, Hong J, Yang G-Y, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr. 2005;81:284S-91S.
57. Sovak M. Grape extract, resveratrol, and its analogs: a review. J Med Food. 2001;4:93-105.
58. Sun, J, Liu RH. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2006;241:124-34.
59. Pupa SM, Menard S, Forti S, Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol. 2002;192:259-67.
60. Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RAR. Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen activated protein kinase mediated events. J Nutr Biochem. 2006;17:117-25.
61. Kondo M, Lamoureaux TL, Neto CC, Hurta RAR, Curtis S, Matchett MD, Yeung H, Sweeney MI, Vaisberg AJ. Proanthocyanidins, anthocyanins and triterpenoids from cranberry fruits: antitumor activity and effects on matrix metalloproteinase expression. J Nutr. 2004;12S:3538S.
62. Vayalil PK, Mittal A, Katiyar SK. Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of MAPK and NFkB. Carcinogenesis. 2004;25:987-95.
63. Auvinen M. Cell transformation, invasion, and angiogenesis: a regulatory role for ornithine decarboxylase and polyamines? J. Natl. Cancer Inst. 1997;89:533-7.
64. 1-acetyltransferase (SSAT) expression in H-ras transformed cells [Abstract 507.2]. FASEB J. 2005;19(4):A825.
65. Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res. 2006;85:235-9.
66. Seeram NP, Momin RA, Nair MG, Bourquin LD. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine. 2001;8:362-9.
67. Seeram NP, Zhang Y, Nair MG. Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr Cancer. 2003;46:101-6.
68. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp R, DuBois R. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest. 1997;99:2254-9.
69. Fournier DB, Gordon GB. COX-2 and colon cancer: potential targets for chemoprevention. J Cell Biochem. 2000;77:97-102.
70. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannings and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem. 2006;54:980-5.
71. Safayhi H, Sailer E-R. Anti-Inflammatory actions of pentacyclic triterpenes. Planta Med. 1997;63:487-93.
72. Recio MC, Giner RM, Manez S, Gueho J, Julien HR, Hostettmann K, Rios JL. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med. 1995;61:9-12.
73. Baricevic D, Sosa S, Della Loggia R, Tubaro A, Simonovska B, Krasna A, Zupancic A. Topical antiinflammatory activity of Salvia officianalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol. 2001;75:125-32.
74. Ringbom T, Segura L, Noreen Y, Perera P, Bohlin L. Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis. J Nat Prod. 1998;61:1212-1215.
75. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 2000;60:2399-404.
76. You HJ, Choi CY, Kim JY, Park SJ, Hahm K-S, Jeong HG. Ursolic acid enhances nitric oxide and tumor necrosis factor-a production via nuclear factor-kB activation in the resting macrophages. FEBS Lett. 2001;509:156-60.
77. O'Leary K, de Pascual-Teresa S, Needs PW, Bao Y-P, O'Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res. 2004;551:245-54.
78. de Pascual-Teresa S, Johnston KL, DuPont MS, O'Leary KA, Needs PW, Morgan LM, Clifford MN, Bao Y, Williamson G. Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J Nutr. 2004;134:552-7.
79. Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ, Neckers L, Jung Y. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res. 2005;22:1499-509